Ligand validation:2XDR

GOL: GLYCEROL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2XDR_GOL_B_1493	70%	51%	0.127	0.944	0.57	1.3	-	-	2	0	100%	1
2XDR_GOL_D_1494	53%	57%	0.144	0.906	0.52	1.1	-	-	0	0	100%	1
2XDR_GOL_B_1494	46%	51%	0.179	0.916	0.57	1.32	-	-	1	0	100%	1
2XDR_GOL_C_1491	40%	51%	0.203	0.913	0.59	1.27	-	-	3	0	100%	1
2XDR_GOL_D_1491	36%	50%	0.194	0.886	0.57	1.34	-	-	2	0	100%	1
2XDR_GOL_D_1492	31%	53%	0.261	0.931	0.56	1.25	-	-	1	0	100%	1
2XDR_GOL_C_1492	21%	51%	0.303	0.917	0.56	1.32	-	-	1	0	100%	1
2XDR_GOL_A_1491	21%	45%	0.226	0.837	0.57	1.51	-	1	1	0	100%	1
2XDR_GOL_C_1493	19%	50%	0.263	0.862	0.54	1.38	-	-	1	0	100%	1
2XDR_GOL_B_1492	19%	50%	0.311	0.91	0.58	1.33	-	-	1	0	100%	1
2XDR_GOL_D_1493	12%	46%	0.293	0.826	0.61	1.44	-	1	0	0	100%	1
2XDR_GOL_B_1491	7%	48%	0.318	0.769	0.53	1.47	-	1	0	0	100%	1
2XDR_GOL_C_1495	7%	50%	0.39	0.84	0.6	1.3	-	-	1	0	100%	1
2XDR_GOL_C_1494	2%	52%	0.379	0.671	0.52	1.3	-	1	0	0	100%	1
2WOX_GOL_B_1497	79%	73%	0.127	0.973	0.47	0.56	-	-	2	0	100%	1
2WME_GOL_F_1495	76%	75%	0.109	0.945	0.37	0.6	-	-	1	0	100%	1
3ZQA_GOL_A_1493	66%	88%	0.119	0.923	0.36	0.31	-	-	4	0	100%	1
1SSX_GOL_A_249	100%	73%	0.032	0.994	0.64	0.43	-	-	0	0	100%	0.8
4CJ0_GOL_A_1582	100%	73%	0.037	0.994	0.7	0.35	-	-	0	0	100%	1
7T8M_GOL_A_401	100%	40%	0.039	0.991	1.21	1.14	-	-	0	0	100%	1
4UQL_GOL_Q_1553	100%	89%	0.04	0.991	0.35	0.29	-	-	0	0	100%	1
8A3H_GOL_A_601	100%	92%	0.041	0.989	0.27	0.27	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.